Fig. 1From: Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s diseaseDisposition of subjects in the Bexarotene Amyloid Treatment for Alzheimer’s Disease trial. MMSE Mini Mental State Examination, MRI magnetic resonance imagingBack to article page